Published in J Antimicrob Chemother on May 22, 2014
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses. Immunol Rev (2015) 1.45
Autophagy in the fight against tuberculosis. DNA Cell Biol (2015) 0.97
Is There Potential for Repurposing Statins as Novel Antimicrobials? Antimicrob Agents Chemother (2016) 0.93
New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics. Immunol Rev (2015) 0.90
Statin adjunctive therapy shortens the duration of TB treatment in mice. J Antimicrob Chemother (2016) 0.90
Cell death and autophagy in tuberculosis. Semin Immunol (2014) 0.85
High Prevalence and Heterogeneity of Diabetes in Patients With TB in South India: A Report from the Effects of Diabetes on Tuberculosis Severity (EDOTS) Study. Chest (2016) 0.85
Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious Diseases. Clin Infect Dis (2015) 0.84
Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis. BMC Med (2016) 0.83
Effects of Lipid-Lowering Drugs on Vancomycin Susceptibility of Mycobacteria. Antimicrob Agents Chemother (2016) 0.82
Granulomas and Inflammation: Host-Directed Therapies for Tuberculosis. Front Immunol (2016) 0.79
Sphingosine-1-phosphate Receptor Agonism Reduces Bordetella pertussis-mediated Lung Pathology. J Infect Dis (2014) 0.77
Novel therapies for the treatment of pertussis disease. Pathog Dis (2015) 0.76
Targeting Batf2 for infectious diseases and cancer. Oncotarget (2015) 0.75
Statin Therapy Is Associated with Reduced Risk of Peptic Ulcer Disease in the Taiwanese Population. Front Pharmacol (2017) 0.75
Adjunct Strategies for Tuberculosis Vaccines: Modulating Key Immune Cell Regulatory Mechanisms to Potentiate Vaccination. Front Immunol (2016) 0.75
Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog (2008) 3.02
The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps. Am J Respir Crit Care Med (2001) 2.54
Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Arch Intern Med (2009) 2.43
Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS Pathog (2011) 1.99
New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development. Antimicrob Agents Chemother (2008) 1.50
Mycobacterium tuberculosis-driven targeted recalibration of macrophage lipid homeostasis promotes the foamy phenotype. Cell Host Microbe (2012) 1.47
Salmonella enterica serovar Typhimurium requires nonsterol precursors of the cholesterol biosynthetic pathway for intracellular proliferation. Infect Immun (2004) 1.36
Mycobacterium tuberculosis modulates macrophage lipid-sensing nuclear receptors PPARγ and TR4 for survival. J Immunol (2012) 1.30
Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs. PLoS Pathog (2011) 1.29
Statin therapy reduces the mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation. J Infect Dis (2013) 1.26
Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice. PLoS One (2011) 1.20
Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome. Intensive Care Med (2006) 1.15
Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2013) 1.12
The global alliance for tuberculosis drug development--accomplishments and future directions. Clin Chest Med (2005) 1.05
Simvastatin protects against the development of endometriosis in a nude mouse model. J Clin Endocrinol Metab (2009) 1.05
Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas. PLoS One (2012) 1.04
Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models. J Antimicrob Chemother (2011) 0.99
Effect of simvastatin, an established lipid-lowering drug, on pulmonary Chlamydia pneumoniae infection in mice. Antimicrob Agents Chemother (2005) 0.96
NPC1 repression contributes to lipid accumulation in human macrophages exposed to environmental aryl hydrocarbons. Cardiovasc Res (2009) 0.93
Statin adjunctive therapy shortens the duration of TB treatment in mice. J Antimicrob Chemother (2016) 0.90
Mycobacterial Protein Tyrosine Phosphatases A and B Inhibitors Augment the Bactericidal Activity of the Standard Anti-tuberculosis Regimen. ACS Infect Dis (2015) 0.75